European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai
The committee said Leqembi’s effect on delaying cognitive decline does not outweigh “the risk of serious side effects associated with the medicine.”
Similar Posts
‘Diff’rent Strokes’ star Todd Bridges claims troubled Gary Coleman was exploited by ‘greedy people’
Todd Bridges believes Gary Coleman could have been saved from the pitfalls of child stardom if he wasn’t forced to be a breadwinner. “That’s what happens when people get greedy,” Coleman’s “Diff’rent Strokes” co-star told Fox News Digital. “They tend to just take money … and steal things. We all lost some money to some…
Don’t get caught in the ‘Apple ID suspended’ phishing scam
Scammers keep coming up with new and, honestly, pretty clever ways to trick people. They socially engineer their phishing emails and messages so well that even the most tech-savvy users have to think twice. One example is the “Apple ID Suspended” phishing scam. You might have seen it before since it’s been going around for…
Cowboys’ Ezekiel Elliott out vs. Falcons for disciplinary reasons: report
Ezekiel Elliott’s second stint with the Dallas Cowboys has been largely disappointing. But the three-time Pro Bowler’s season appeared to reach a new low less than 48 hours before the Cowboys’ Week 9 game. On Saturday, Clarence Hill Jr., who spent nearly three decades covering the Cowboys on behalf of the Fort Worth Star-Telegram, reported…
1st T20I: Time to reboot for Team India
Ahead of the Champions Trophy, India’s cricket team seeks a morale boost by winning the T20I series against England. The series starts at Eden Gardens. Key players like Sanju Samson and Nitish Kumar Reddy are under watch, while England relies on Jos Buttler and Jacob Bethell. Coach Brendon McCullum remains optimistic about England’s chances.
